机译:炎症性肠病患者淋巴瘤特征:系统评价
Univ Lorraine Nancy Univ Hosp Dept Gastroenterol Nancy France;
Univ Lorraine Inserm U1256 Nutr Genet &
Exposure Environm Risks F-54000 Nancy France;
Univ Lorraine Inserm U1256 Nutr Genet &
Exposure Environm Risks F-54000 Nancy France;
Univ Paris St Louis Hosp AP HP Hematooncol Paris France;
Sorbonne Univ Hop St Antoine AP HP Dept Gastroenterol F-75012 Paris France;
Humanitas Clin &
Res Ctr IRCCS IBD Ctr Dept Gastroenterol Rozzano Milan Italy;
Univ Lorraine Inserm U1256 Nutr Genet &
Exposure Environm Risks F-54000 Nancy France;
Univ Lorraine Inserm U1256 Nutr Genet &
Exposure Environm Risks F-54000 Nancy France;
Univ Lorraine Inserm U1256 Nutr Genet &
Exposure Environm Risks F-54000 Nancy France;
Univ Lorraine Inserm U1256 Nutr Genet &
Exposure Environm Risks F-54000 Nancy France;
Univ Lorraine Nancy Univ Hosp Dept Gastroenterol Nancy France;
Inflammatory bowel disease; lymphoma; lymphoproliferative disorders; inflammatory bowel disease-associated cancer;
机译:炎症性肠病患者是否存在与抗肿瘤坏死因子药物相关的淋巴瘤风险?观察研究的系统综述
机译:炎症性肠病患者是否存在与抗肿瘤坏死因子药物相关的淋巴瘤风险?观察研究的系统综述
机译:用抗肿瘤坏死因子α剂治疗炎症性肠病患者淋巴瘤的风险:系统评价和荟萃分析
机译:用组织学引导质谱分析猫鼻炎肠疾病和小细胞淋巴瘤的分化
机译:肠道制剂对健康受试者中结肠菌细菌植物菌的影响和炎症性肠病患者
机译:炎症性肠病患者是否存在与抗肿瘤坏死因子药物相关的淋巴瘤风险?观察研究的系统评价
机译:炎症性肠病患者淋巴瘤的特征:系统评价
机译:炎症性肠病进展为癌症:如果没有淋巴管或淋巴结(或促血管生成素2),患者会更好吗?